Discontinuation report PROCTOSEDYL
| Report ID | 220351 |
| Drug Identification Number | 02223252 |
| Brand name | PROCTOSEDYL |
| Common or Proper name | hydrocortisone - framycetin - dibucaine - esculin |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ESCULIN FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE HYDROCORTISONE |
| Strength(s) | 1% 1% 0.5% 0.5% |
| Dosage form(s) | OINTMENT |
| Route of administration | RECTAL RECTAL |
| Packaging size | 15G and 30 G tube |
| Anatomical Therapeutical Chemical (ATC) code | C05AA |
| Anatomical Therapeutical Chemical (ATC) description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-06-30 |
| Actual discontinuation date | 2024-04-24 |
| Remaining supply date | 2024-04-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Discontinued - with the actual depletion date as April 24, 2024 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: [email protected] Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-07-09 | French | Compare |
| v8 | 2024-07-09 | English | Compare |
| v7 | 2024-07-08 | English | Compare |
| v6 | 2024-02-23 | French | Compare |
| v5 | 2024-02-23 | English | Compare |
| v4 | 2024-02-23 | French | Compare |
| v3 | 2024-02-23 | English | Compare |
| v2 | 2024-02-23 | French | Compare |
| v1 | 2024-02-23 | English | Compare |
Showing 1 to 9 of 9